Xylem Inc (NYSE:XYL) Shares Bought by Triodos Investment Management BV

Triodos Investment Management BV grew its holdings in Xylem Inc (NYSE:XYL) by 0.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 241,730 shares of the industrial products company’s stock after buying an additional 730 shares during the quarter. Xylem makes up 4.9% of Triodos Investment Management BV’s portfolio, making the stock its 6th largest position. Triodos Investment Management BV owned 0.13% of Xylem worth $19,247,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. City Holding Co. boosted its holdings in Xylem by 116.7% in the third quarter. City Holding Co. now owns 325 shares of the industrial products company’s stock valued at $26,000 after acquiring an additional 175 shares during the last quarter. FinTrust Capital Advisors LLC boosted its holdings in Xylem by 1,530.4% in the second quarter. FinTrust Capital Advisors LLC now owns 375 shares of the industrial products company’s stock valued at $31,000 after acquiring an additional 352 shares during the last quarter. Winthrop Partners WNY LLC bought a new position in Xylem in the third quarter valued at about $32,000. Private Ocean LLC bought a new position in Xylem in the second quarter valued at about $33,000. Finally, Valeo Financial Advisors LLC boosted its holdings in Xylem by 500.0% in the third quarter. Valeo Financial Advisors LLC now owns 420 shares of the industrial products company’s stock valued at $33,000 after acquiring an additional 350 shares during the last quarter. Institutional investors own 84.81% of the company’s stock.

In other news, SVP Colin R. Sabol sold 4,099 shares of Xylem stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $78.37, for a total transaction of $321,238.63. Following the transaction, the senior vice president now owns 33,518 shares in the company, valued at approximately $2,626,805.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Markos I. Tambakeras sold 2,860 shares of Xylem stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $78.95, for a total value of $225,797.00. Following the transaction, the director now owns 43,530 shares in the company, valued at approximately $3,436,693.50. The disclosure for this sale can be found here. Insiders have sold a total of 16,959 shares of company stock worth $1,313,986 in the last quarter. 0.85% of the stock is currently owned by company insiders.

Several equities analysts recently issued reports on the company. Jefferies Financial Group initiated coverage on Xylem in a report on Friday, September 20th. They issued a “buy” rating and a $90.00 price target on the stock. ValuEngine cut Xylem from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Royal Bank of Canada set a $79.00 target price on Xylem and gave the stock a “buy” rating in a report on Friday, November 1st. Cfra cut Xylem from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Finally, Credit Suisse Group set a $78.00 target price on Xylem and gave the stock a “hold” rating in a report on Friday, November 1st. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $82.30.

XYL traded up $0.01 during midday trading on Friday, reaching $77.33. 949,343 shares of the company were exchanged, compared to its average volume of 837,767. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.15 and a current ratio of 1.55. Xylem Inc has a one year low of $60.65 and a one year high of $85.67. The stock has a market capitalization of $14.35 billion, a P/E ratio of 26.85, a PEG ratio of 1.60 and a beta of 1.18. The stock’s 50-day simple moving average is $78.69 and its 200 day simple moving average is $78.88.

Xylem (NYSE:XYL) last issued its earnings results on Thursday, October 31st. The industrial products company reported $0.82 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.82. Xylem had a return on equity of 19.14% and a net margin of 9.65%. The firm had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter last year, the business earned $0.77 earnings per share. The company’s revenue was up .7% compared to the same quarter last year. On average, research analysts anticipate that Xylem Inc will post 3.02 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 5th. Stockholders of record on Thursday, October 31st will be issued a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 1.24%. The ex-dividend date is Wednesday, October 30th. Xylem’s dividend payout ratio (DPR) is presently 33.33%.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Read More: What is the Bid-Ask Spread?

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.